| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Bishop John L serves as a Director at VCYT. Across recent SEC filings that breaks down to 0 buys and 2 sells. Those positions are worth an estimated $1.0M at current prices.
The biggest single holding is VCYT (~$1.0M) as Director. The recent filings there lean toward selling, a net 20,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2023 | VCYT Veracyte, Inc. | Director | Sale+OE | 20,000 | $30.25 | $605,002.00 | -37.6% | -28.5% | -15.1% |